Conservative treatment

Last updated

Conservative treatment is a type of medical treatment defined by the avoidance of invasive procedures, such as surgery, usually with the intent to preserve function or body parts, maintain quality of life, or avoid the risk of complications from surgery. [1] The effectiveness of a conservative treatment plan depends on patient/provider goals as well as the stage and type of disease or injury.

Contents

Effectiveness of conservative treatment

Kidney failure

In patients with advanced kidney failure, Conservative Kidney Management (CKM), or Comprehensive Conservative Care (CCC), is an alternative to dialysis or transplant. CKM includes management of pain and other symptoms, nutrition, and preservation of kidney function through noninvasive methods with an emphasis on quality of life. [2] [3] Studies of treatment strategies among elderly patients show that while more aggressive treatments such as dialysis may increase life expectancy, this effect diminishes among patients over 80, while patients who choose conservative treatment report a higher quality of life. [4] One barrier to establishing strong provider-patient communication about CKM is disagreement among providers over the specific terms used, including "conservative treatment," "conservative care," "supportive care," "palliative care," "Conservative Kidney Management," and "Comprehensive Conservative Care." [3]

Appendicitis

Conservative treatment of acute appendicitis has been attempted with mixed results. Across all ages, patients who received antibiotic therapy had one-year recurrence rates of 13%-38%. Most patients who attempted a second round of antibiotic therapy eventually required surgical treatment. [5]

The overwhelming of hospitals during the COVID-19 pandemic led some providers to shift from immediate surgical treatment of acute appendicitis to antibiotic therapy in pediatric patients. [6] In studies of uncomplicated cases of pediatric appendicitis, nonoperative management was inferior to operative management (surgery), resulting in significantly higher rates of failure initially, after one year, and overall. These patients were also more likely to experience adverse advents and rehospitalization. [7] Though some carefully selected patients may benefit from this therapy, [8] surgery remains the standard treatment strategy.

Cancer

Standard treatment for endometrial cancer is total hysterectomy. Conservative therapy for patients with endometrial atypical hyperplasia or low grade early stage endometrial cancer involves hysteroscopic resection followed by hormone therapy. This treatment has been shown to be safe and effective in specific types of low-risk patients who wish to preserve their fertility. [9] [10]

Standard treatment for ductal carcinoma in situ of the breast is surgical resection. In low-risk cases detected through screening, patients who received active surveillance experienced similar 5 and 10-year outcomes as patients who received surgical treatment. [11]

References

  1. ↑ "Medical Definition of CONSERVATIVE". www.merriam-webster.com. Retrieved 2016-04-25.
  2. ↑ "Conservative Management for Kidney Failure - NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 2025-11-07.
  3. 1 2 Hamroun, Aghiles; Glowacki, François; Frimat, Luc (2023-10-31). "Comprehensive conservative care: what doctors say, what patients hear" . Nephrology Dialysis Transplantation. 38 (11): 2428–2443. doi:10.1093/ndt/gfad088. ISSN   0931-0509.
  4. ↑ Buur, Louise Engelbrecht; Madsen, Jens Kristian; Eidemak, Inge; Krarup, Elizabeth; Lauridsen, Thomas Guldager; Taasti, Lena Helbo; Finderup, Jeanette (2021-09-11). "Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review". BMC Nephrology. 22 (1): 307. doi: 10.1186/s12882-021-02516-6 . ISSN   1471-2369. PMC   8434727 . PMID   34507554.
  5. ↑ Chin, Xinlin; Mallika Arachchige, Sachini; Orbell-Smith, Jane L; Da Rocha, Daniela; Gandhi, Anil (2024-01-21). "Conservative Versus Surgical Management of Acute Appendicitis: A Systematic Review". Cureus. 16 (1) e52697. doi: 10.7759/cureus.52697 . ISSN   2168-8184. PMC   10879736 . PMID   38384640.
  6. ↑ Ghazwani, Salman M (2022-12-16). "Moving to Medical Treatment for COVID-19 Influence on Pediatric Appendicitis: A Meta-Analysis". Cureus. 14 (12) e32601. doi: 10.7759/cureus.32601 . ISSN   2168-8184. PMC   9840872 . PMID   36654629.
  7. ↑ Lu, Kai; Shu, Shilong; Wang, Junwei; Mao, Weijian; Zhang, Faqiang; Cheng, Yong; Yang, Hua (November 2025). "Can antibiotic therapy replace surgery in pediatric acute uncomplicated appendicitis? An updated meta-analysis of randomized controlled trials" . Journal of Pediatric Surgery. 60 (11) 162565. doi:10.1016/j.jpedsurg.2025.162565. PMID   40834918.
  8. ↑ Decker, Emily; Ndzi, Agnes; Kenny, Simon; Harwood, Rachel (June 2024). "Systematic Review and Meta-analysis to Compare the Short- and Long-term Outcomes of Non-operative Management With Early Operative Management of Simple Appendicitis in Children After the COVID-19 Pandemic". Journal of Pediatric Surgery. 59 (6): 1050–1057. doi: 10.1016/j.jpedsurg.2023.12.021 . PMID   38158255.
  9. ↑ Zhao, Shuangshuang; Zhang, Jingying; Yan, Ye; Tian, Lina; Chen, Lingli; Zheng, Xingyu; Sun, Yiqing; Tian, Wenyan; Xue, Fengxia; Wang, Yingmei (August 2024). "Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis". Acta Obstetricia et Gynecologica Scandinavica. 103 (8): 1498–1512. doi:10.1111/aogs.14815. ISSN   0001-6349. PMC   11266644 . PMID   38382917.
  10. ↑ Uccella, Stefano; Zorzato, Pier; Dababou, Susan; Bosco, Mariachiara; Torella, Marco; Braga, Andrea; Frigerio, Matteo; Gardella, Barbara; Cianci, Stefano; Laganà, Antonio; Franchi, Massimo; Garzon, Simone (2022-09-11). "Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women". Medicina. 58 (9): 1256. doi: 10.3390/medicina58091256 . ISSN   1648-9144. PMC   9504942 . PMID   36143933.
  11. ↑ Co, M.; Cheng, K.C.K.; Yeung, Y.H.; Lau, K.C.; Qian, Z.; Wong, C.M.; Wong, B.Y.; Sin, E.L.K.; Wong, H.Y.S.; Ma, C.H. (April 2023). "Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis" . Clinical Oncology. 35 (4): 255–261. doi:10.1016/j.clon.2023.01.019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.